nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosamprenavir—CYP3A4—Fingolimod—multiple sclerosis	0.175	0.246	CbGbCtD
Fosamprenavir—CYP3A4—Methylprednisolone—multiple sclerosis	0.113	0.158	CbGbCtD
Fosamprenavir—CYP3A4—Triamcinolone—multiple sclerosis	0.0855	0.12	CbGbCtD
Fosamprenavir—CYP3A4—Mitoxantrone—multiple sclerosis	0.0823	0.116	CbGbCtD
Fosamprenavir—CYP3A4—Betamethasone—multiple sclerosis	0.0733	0.103	CbGbCtD
Fosamprenavir—CYP3A4—Prednisolone—multiple sclerosis	0.0724	0.102	CbGbCtD
Fosamprenavir—CYP3A4—Prednisone—multiple sclerosis	0.0683	0.0959	CbGbCtD
Fosamprenavir—CYP3A4—Dexamethasone—multiple sclerosis	0.0427	0.0599	CbGbCtD
Fosamprenavir—Flatulence—Cladribine—multiple sclerosis	0.00129	0.00448	CcSEcCtD
Fosamprenavir—Diarrhoea—Fingolimod—multiple sclerosis	0.00129	0.00448	CcSEcCtD
Fosamprenavir—Aspartate aminotransferase increased—Mitoxantrone—multiple sclerosis	0.00129	0.00447	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Mitoxantrone—multiple sclerosis	0.00126	0.00437	CcSEcCtD
Fosamprenavir—Dizziness—Fingolimod—multiple sclerosis	0.00124	0.00433	CcSEcCtD
Fosamprenavir—Hypercholesterolaemia—Prednisone—multiple sclerosis	0.00124	0.00431	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Triamcinolone—multiple sclerosis	0.00124	0.0043	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Methylprednisolone—multiple sclerosis	0.00124	0.00429	CcSEcCtD
Fosamprenavir—Haemoglobin—Azathioprine—multiple sclerosis	0.00123	0.00427	CcSEcCtD
Fosamprenavir—Haemorrhage—Azathioprine—multiple sclerosis	0.00122	0.00424	CcSEcCtD
Fosamprenavir—Headache—Fingolimod—multiple sclerosis	0.00118	0.0041	CcSEcCtD
Fosamprenavir—Erythema multiforme—Azathioprine—multiple sclerosis	0.00115	0.00401	CcSEcCtD
Fosamprenavir—Neutropenia—Mitoxantrone—multiple sclerosis	0.00115	0.00401	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Dexamethasone—multiple sclerosis	0.00112	0.0039	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Betamethasone—multiple sclerosis	0.00112	0.0039	CcSEcCtD
Fosamprenavir—Myalgia—Cladribine—multiple sclerosis	0.00111	0.00387	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Mitoxantrone—multiple sclerosis	0.00111	0.00387	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.00111	0.00384	CcSEcCtD
Fosamprenavir—Immune system disorder—Azathioprine—multiple sclerosis	0.0011	0.00383	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Mitoxantrone—multiple sclerosis	0.00108	0.00377	CcSEcCtD
Fosamprenavir—Myocardial infarction—Mitoxantrone—multiple sclerosis	0.00108	0.00375	CcSEcCtD
Fosamprenavir—Nervous system disorder—Cladribine—multiple sclerosis	0.00105	0.00364	CcSEcCtD
Fosamprenavir—Skin disorder—Cladribine—multiple sclerosis	0.00104	0.0036	CcSEcCtD
Fosamprenavir—Anorexia—Cladribine—multiple sclerosis	0.00102	0.00353	CcSEcCtD
Fosamprenavir—Inflammation—Methotrexate—multiple sclerosis	0.00101	0.00351	CcSEcCtD
Fosamprenavir—Haemoglobin—Mitoxantrone—multiple sclerosis	0.000992	0.00345	CcSEcCtD
Fosamprenavir—Haemorrhage—Mitoxantrone—multiple sclerosis	0.000987	0.00343	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Prednisone—multiple sclerosis	0.000978	0.0034	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.000972	0.00338	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Methylprednisolone—multiple sclerosis	0.000947	0.00329	CcSEcCtD
Fosamprenavir—Decreased appetite—Cladribine—multiple sclerosis	0.000928	0.00322	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000921	0.0032	CcSEcCtD
Fosamprenavir—Fatigue—Cladribine—multiple sclerosis	0.00092	0.0032	CcSEcCtD
Fosamprenavir—Myalgia—Azathioprine—multiple sclerosis	0.000905	0.00315	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000899	0.00312	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Prednisolone—multiple sclerosis	0.000889	0.00309	CcSEcCtD
Fosamprenavir—Myocardial infarction—Prednisolone—multiple sclerosis	0.000884	0.00307	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000873	0.00303	CcSEcCtD
Fosamprenavir—Body temperature increased—Cladribine—multiple sclerosis	0.000844	0.00293	CcSEcCtD
Fosamprenavir—Abdominal pain—Cladribine—multiple sclerosis	0.000844	0.00293	CcSEcCtD
Fosamprenavir—Skin disorder—Azathioprine—multiple sclerosis	0.000843	0.00293	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.000818	0.00284	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Methotrexate—multiple sclerosis	0.000817	0.00284	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.000816	0.00284	CcSEcCtD
Fosamprenavir—Haemoglobin—Prednisolone—multiple sclerosis	0.000814	0.00283	CcSEcCtD
Fosamprenavir—Myocardial infarction—Triamcinolone—multiple sclerosis	0.000813	0.00283	CcSEcCtD
Fosamprenavir—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.000811	0.00282	CcSEcCtD
Fosamprenavir—Haemorrhage—Prednisolone—multiple sclerosis	0.00081	0.00281	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.00079	0.00275	CcSEcCtD
Fosamprenavir—Hypersensitivity—Cladribine—multiple sclerosis	0.000786	0.00273	CcSEcCtD
Fosamprenavir—Asthenia—Cladribine—multiple sclerosis	0.000766	0.00266	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Betamethasone—multiple sclerosis	0.000762	0.00265	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Dexamethasone—multiple sclerosis	0.000762	0.00265	CcSEcCtD
Fosamprenavir—Pruritus—Cladribine—multiple sclerosis	0.000755	0.00262	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Prednisone—multiple sclerosis	0.00075	0.00261	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000749	0.0026	CcSEcCtD
Fosamprenavir—Haemoglobin—Triamcinolone—multiple sclerosis	0.000749	0.0026	CcSEcCtD
Fosamprenavir—Haemoglobin—Methylprednisolone—multiple sclerosis	0.000747	0.0026	CcSEcCtD
Fosamprenavir—Haemorrhage—Triamcinolone—multiple sclerosis	0.000745	0.00259	CcSEcCtD
Fosamprenavir—Haemorrhage—Methylprednisolone—multiple sclerosis	0.000743	0.00258	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.000742	0.00258	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.000742	0.00258	CcSEcCtD
Fosamprenavir—Myocardial infarction—Dexamethasone—multiple sclerosis	0.000738	0.00256	CcSEcCtD
Fosamprenavir—Myocardial infarction—Betamethasone—multiple sclerosis	0.000738	0.00256	CcSEcCtD
Fosamprenavir—Myalgia—Mitoxantrone—multiple sclerosis	0.000732	0.00254	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.00073	0.00254	CcSEcCtD
Fosamprenavir—Diarrhoea—Cladribine—multiple sclerosis	0.00073	0.00254	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000709	0.00247	CcSEcCtD
Fosamprenavir—Dizziness—Cladribine—multiple sclerosis	0.000706	0.00245	CcSEcCtD
Fosamprenavir—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.00069	0.0024	CcSEcCtD
Fosamprenavir—Neutropenia—Prednisone—multiple sclerosis	0.000688	0.00239	CcSEcCtD
Fosamprenavir—Abdominal pain—Azathioprine—multiple sclerosis	0.000686	0.00238	CcSEcCtD
Fosamprenavir—Body temperature increased—Azathioprine—multiple sclerosis	0.000686	0.00238	CcSEcCtD
Fosamprenavir—Skin disorder—Mitoxantrone—multiple sclerosis	0.000681	0.00237	CcSEcCtD
Fosamprenavir—Haemoglobin—Dexamethasone—multiple sclerosis	0.000679	0.00236	CcSEcCtD
Fosamprenavir—Haemoglobin—Betamethasone—multiple sclerosis	0.000679	0.00236	CcSEcCtD
Fosamprenavir—Vomiting—Cladribine—multiple sclerosis	0.000678	0.00236	CcSEcCtD
Fosamprenavir—Haemorrhage—Betamethasone—multiple sclerosis	0.000676	0.00235	CcSEcCtD
Fosamprenavir—Haemorrhage—Dexamethasone—multiple sclerosis	0.000676	0.00235	CcSEcCtD
Fosamprenavir—Rash—Cladribine—multiple sclerosis	0.000673	0.00234	CcSEcCtD
Fosamprenavir—Dermatitis—Cladribine—multiple sclerosis	0.000672	0.00234	CcSEcCtD
Fosamprenavir—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000671	0.00233	CcSEcCtD
Fosamprenavir—Anorexia—Mitoxantrone—multiple sclerosis	0.000669	0.00232	CcSEcCtD
Fosamprenavir—Headache—Cladribine—multiple sclerosis	0.000668	0.00232	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Prednisone—multiple sclerosis	0.000663	0.00231	CcSEcCtD
Fosamprenavir—Malnutrition—Methylprednisolone—multiple sclerosis	0.000647	0.00225	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Prednisone—multiple sclerosis	0.000646	0.00225	CcSEcCtD
Fosamprenavir—Angioedema—Prednisolone—multiple sclerosis	0.000644	0.00224	CcSEcCtD
Fosamprenavir—Myocardial infarction—Prednisone—multiple sclerosis	0.000643	0.00223	CcSEcCtD
Fosamprenavir—Hypersensitivity—Azathioprine—multiple sclerosis	0.000639	0.00222	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000639	0.00222	CcSEcCtD
Fosamprenavir—Nausea—Cladribine—multiple sclerosis	0.000634	0.0022	CcSEcCtD
Fosamprenavir—Decreased appetite—Mitoxantrone—multiple sclerosis	0.00061	0.00212	CcSEcCtD
Fosamprenavir—Fatigue—Mitoxantrone—multiple sclerosis	0.000605	0.0021	CcSEcCtD
Fosamprenavir—Diarrhoea—Azathioprine—multiple sclerosis	0.000594	0.00206	CcSEcCtD
Fosamprenavir—Angioedema—Triamcinolone—multiple sclerosis	0.000592	0.00206	CcSEcCtD
Fosamprenavir—Haemoglobin—Prednisone—multiple sclerosis	0.000592	0.00206	CcSEcCtD
Fosamprenavir—Angioedema—Methylprednisolone—multiple sclerosis	0.000591	0.00205	CcSEcCtD
Fosamprenavir—Haemorrhage—Prednisone—multiple sclerosis	0.000589	0.00205	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Prednisone—multiple sclerosis	0.000578	0.00201	CcSEcCtD
Fosamprenavir—Neutropenia—Methotrexate—multiple sclerosis	0.000575	0.002	CcSEcCtD
Fosamprenavir—Dizziness—Azathioprine—multiple sclerosis	0.000574	0.00199	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000574	0.00199	CcSEcCtD
Fosamprenavir—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000554	0.00193	CcSEcCtD
Fosamprenavir—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000554	0.00193	CcSEcCtD
Fosamprenavir—Myalgia—Triamcinolone—multiple sclerosis	0.000552	0.00192	CcSEcCtD
Fosamprenavir—Vomiting—Azathioprine—multiple sclerosis	0.000552	0.00192	CcSEcCtD
Fosamprenavir—Myalgia—Methylprednisolone—multiple sclerosis	0.000551	0.00191	CcSEcCtD
Fosamprenavir—Rash—Azathioprine—multiple sclerosis	0.000547	0.0019	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000547	0.0019	CcSEcCtD
Fosamprenavir—Dermatitis—Azathioprine—multiple sclerosis	0.000547	0.0019	CcSEcCtD
Fosamprenavir—Headache—Azathioprine—multiple sclerosis	0.000544	0.00189	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000543	0.00189	CcSEcCtD
Fosamprenavir—Angioedema—Dexamethasone—multiple sclerosis	0.000538	0.00187	CcSEcCtD
Fosamprenavir—Angioedema—Betamethasone—multiple sclerosis	0.000538	0.00187	CcSEcCtD
Fosamprenavir—Immune system disorder—Prednisone—multiple sclerosis	0.000532	0.00185	CcSEcCtD
Fosamprenavir—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000518	0.0018	CcSEcCtD
Fosamprenavir—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000517	0.0018	CcSEcCtD
Fosamprenavir—Nausea—Azathioprine—multiple sclerosis	0.000515	0.00179	CcSEcCtD
Fosamprenavir—Skin disorder—Methylprednisolone—multiple sclerosis	0.000513	0.00178	CcSEcCtD
Fosamprenavir—Malnutrition—Prednisone—multiple sclerosis	0.000512	0.00178	CcSEcCtD
Fosamprenavir—Asthenia—Mitoxantrone—multiple sclerosis	0.000503	0.00175	CcSEcCtD
Fosamprenavir—Myalgia—Dexamethasone—multiple sclerosis	0.000501	0.00174	CcSEcCtD
Fosamprenavir—Myalgia—Betamethasone—multiple sclerosis	0.000501	0.00174	CcSEcCtD
Fosamprenavir—Haemoglobin—Methotrexate—multiple sclerosis	0.000494	0.00172	CcSEcCtD
Fosamprenavir—Haemorrhage—Methotrexate—multiple sclerosis	0.000492	0.00171	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000486	0.00169	CcSEcCtD
Fosamprenavir—Urethral disorder—Methotrexate—multiple sclerosis	0.000482	0.00168	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000482	0.00168	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000481	0.00167	CcSEcCtD
Fosamprenavir—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00048	0.00167	CcSEcCtD
Fosamprenavir—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000471	0.00164	CcSEcCtD
Fosamprenavir—Nervous system disorder—Betamethasone—multiple sclerosis	0.000471	0.00164	CcSEcCtD
Fosamprenavir—Angioedema—Prednisone—multiple sclerosis	0.000468	0.00163	CcSEcCtD
Fosamprenavir—Erythema multiforme—Methotrexate—multiple sclerosis	0.000465	0.00162	CcSEcCtD
Fosamprenavir—Anorexia—Betamethasone—multiple sclerosis	0.000458	0.00159	CcSEcCtD
Fosamprenavir—Anorexia—Dexamethasone—multiple sclerosis	0.000458	0.00159	CcSEcCtD
Fosamprenavir—Cardiac disorder—Methotrexate—multiple sclerosis	0.000456	0.00159	CcSEcCtD
Fosamprenavir—Fatigue—Triamcinolone—multiple sclerosis	0.000456	0.00159	CcSEcCtD
Fosamprenavir—Fatigue—Methylprednisolone—multiple sclerosis	0.000455	0.00158	CcSEcCtD
Fosamprenavir—Vomiting—Mitoxantrone—multiple sclerosis	0.000446	0.00155	CcSEcCtD
Fosamprenavir—Immune system disorder—Methotrexate—multiple sclerosis	0.000444	0.00154	CcSEcCtD
Fosamprenavir—Rash—Mitoxantrone—multiple sclerosis	0.000442	0.00154	CcSEcCtD
Fosamprenavir—Dermatitis—Mitoxantrone—multiple sclerosis	0.000442	0.00154	CcSEcCtD
Fosamprenavir—Headache—Mitoxantrone—multiple sclerosis	0.000439	0.00153	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000437	0.00152	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000437	0.00152	CcSEcCtD
Fosamprenavir—Myalgia—Prednisone—multiple sclerosis	0.000436	0.00152	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000433	0.00151	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000432	0.0015	CcSEcCtD
Fosamprenavir—Malnutrition—Methotrexate—multiple sclerosis	0.000428	0.00149	CcSEcCtD
Fosamprenavir—Hypersensitivity—Prednisolone—multiple sclerosis	0.000424	0.00147	CcSEcCtD
Fosamprenavir—Body temperature increased—Triamcinolone—multiple sclerosis	0.000418	0.00145	CcSEcCtD
Fosamprenavir—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000417	0.00145	CcSEcCtD
Fosamprenavir—Decreased appetite—Dexamethasone—multiple sclerosis	0.000417	0.00145	CcSEcCtD
Fosamprenavir—Decreased appetite—Betamethasone—multiple sclerosis	0.000417	0.00145	CcSEcCtD
Fosamprenavir—Nausea—Mitoxantrone—multiple sclerosis	0.000417	0.00145	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000415	0.00144	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000415	0.00144	CcSEcCtD
Fosamprenavir—Fatigue—Betamethasone—multiple sclerosis	0.000414	0.00144	CcSEcCtD
Fosamprenavir—Fatigue—Dexamethasone—multiple sclerosis	0.000414	0.00144	CcSEcCtD
Fosamprenavir—Nervous system disorder—Prednisone—multiple sclerosis	0.00041	0.00143	CcSEcCtD
Fosamprenavir—Skin disorder—Prednisone—multiple sclerosis	0.000406	0.00141	CcSEcCtD
Fosamprenavir—Anorexia—Prednisone—multiple sclerosis	0.000399	0.00139	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000393	0.00136	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000393	0.00136	CcSEcCtD
Fosamprenavir—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00039	0.00135	CcSEcCtD
Fosamprenavir—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000389	0.00135	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000381	0.00132	CcSEcCtD
Fosamprenavir—Dizziness—Prednisolone—multiple sclerosis	0.000381	0.00132	CcSEcCtD
Fosamprenavir—Asthenia—Triamcinolone—multiple sclerosis	0.00038	0.00132	CcSEcCtD
Fosamprenavir—Abdominal pain—Dexamethasone—multiple sclerosis	0.00038	0.00132	CcSEcCtD
Fosamprenavir—Abdominal pain—Betamethasone—multiple sclerosis	0.00038	0.00132	CcSEcCtD
Fosamprenavir—Body temperature increased—Dexamethasone—multiple sclerosis	0.00038	0.00132	CcSEcCtD
Fosamprenavir—Body temperature increased—Betamethasone—multiple sclerosis	0.00038	0.00132	CcSEcCtD
Fosamprenavir—Asthenia—Methylprednisolone—multiple sclerosis	0.000379	0.00132	CcSEcCtD
Fosamprenavir—Pruritus—Triamcinolone—multiple sclerosis	0.000374	0.0013	CcSEcCtD
Fosamprenavir—Pruritus—Methylprednisolone—multiple sclerosis	0.000374	0.0013	CcSEcCtD
Fosamprenavir—Myalgia—Methotrexate—multiple sclerosis	0.000365	0.00127	CcSEcCtD
Fosamprenavir—Decreased appetite—Prednisone—multiple sclerosis	0.000363	0.00126	CcSEcCtD
Fosamprenavir—Rash—Prednisolone—multiple sclerosis	0.000363	0.00126	CcSEcCtD
Fosamprenavir—Dermatitis—Prednisolone—multiple sclerosis	0.000362	0.00126	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000362	0.00126	CcSEcCtD
Fosamprenavir—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000361	0.00126	CcSEcCtD
Fosamprenavir—Fatigue—Prednisone—multiple sclerosis	0.000361	0.00125	CcSEcCtD
Fosamprenavir—Headache—Prednisolone—multiple sclerosis	0.00036	0.00125	CcSEcCtD
Fosamprenavir—Dizziness—Triamcinolone—multiple sclerosis	0.00035	0.00122	CcSEcCtD
Fosamprenavir—Dizziness—Methylprednisolone—multiple sclerosis	0.000349	0.00121	CcSEcCtD
Fosamprenavir—Asthenia—Betamethasone—multiple sclerosis	0.000344	0.0012	CcSEcCtD
Fosamprenavir—Asthenia—Dexamethasone—multiple sclerosis	0.000344	0.0012	CcSEcCtD
Fosamprenavir—Nervous system disorder—Methotrexate—multiple sclerosis	0.000343	0.00119	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000342	0.00119	CcSEcCtD
Fosamprenavir—Nausea—Prednisolone—multiple sclerosis	0.000342	0.00119	CcSEcCtD
Fosamprenavir—Pruritus—Betamethasone—multiple sclerosis	0.00034	0.00118	CcSEcCtD
Fosamprenavir—Pruritus—Dexamethasone—multiple sclerosis	0.00034	0.00118	CcSEcCtD
Fosamprenavir—Skin disorder—Methotrexate—multiple sclerosis	0.000339	0.00118	CcSEcCtD
Fosamprenavir—Vomiting—Triamcinolone—multiple sclerosis	0.000336	0.00117	CcSEcCtD
Fosamprenavir—Vomiting—Methylprednisolone—multiple sclerosis	0.000336	0.00117	CcSEcCtD
Fosamprenavir—Rash—Triamcinolone—multiple sclerosis	0.000334	0.00116	CcSEcCtD
Fosamprenavir—Dermatitis—Triamcinolone—multiple sclerosis	0.000333	0.00116	CcSEcCtD
Fosamprenavir—Anorexia—Methotrexate—multiple sclerosis	0.000333	0.00116	CcSEcCtD
Fosamprenavir—Rash—Methylprednisolone—multiple sclerosis	0.000333	0.00116	CcSEcCtD
Fosamprenavir—Dermatitis—Methylprednisolone—multiple sclerosis	0.000333	0.00116	CcSEcCtD
Fosamprenavir—Headache—Triamcinolone—multiple sclerosis	0.000332	0.00115	CcSEcCtD
Fosamprenavir—Headache—Methylprednisolone—multiple sclerosis	0.000331	0.00115	CcSEcCtD
Fosamprenavir—Abdominal pain—Prednisone—multiple sclerosis	0.000331	0.00115	CcSEcCtD
Fosamprenavir—Body temperature increased—Prednisone—multiple sclerosis	0.000331	0.00115	CcSEcCtD
Fosamprenavir—Diarrhoea—Betamethasone—multiple sclerosis	0.000329	0.00114	CcSEcCtD
Fosamprenavir—Diarrhoea—Dexamethasone—multiple sclerosis	0.000329	0.00114	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000318	0.00111	CcSEcCtD
Fosamprenavir—Dizziness—Betamethasone—multiple sclerosis	0.000318	0.0011	CcSEcCtD
Fosamprenavir—Dizziness—Dexamethasone—multiple sclerosis	0.000318	0.0011	CcSEcCtD
Fosamprenavir—Nausea—Triamcinolone—multiple sclerosis	0.000314	0.00109	CcSEcCtD
Fosamprenavir—Nausea—Methylprednisolone—multiple sclerosis	0.000314	0.00109	CcSEcCtD
Fosamprenavir—Hypersensitivity—Prednisone—multiple sclerosis	0.000308	0.00107	CcSEcCtD
Fosamprenavir—Vomiting—Dexamethasone—multiple sclerosis	0.000305	0.00106	CcSEcCtD
Fosamprenavir—Vomiting—Betamethasone—multiple sclerosis	0.000305	0.00106	CcSEcCtD
Fosamprenavir—Decreased appetite—Methotrexate—multiple sclerosis	0.000304	0.00106	CcSEcCtD
Fosamprenavir—Rash—Dexamethasone—multiple sclerosis	0.000303	0.00105	CcSEcCtD
Fosamprenavir—Rash—Betamethasone—multiple sclerosis	0.000303	0.00105	CcSEcCtD
Fosamprenavir—Dermatitis—Dexamethasone—multiple sclerosis	0.000302	0.00105	CcSEcCtD
Fosamprenavir—Dermatitis—Betamethasone—multiple sclerosis	0.000302	0.00105	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000302	0.00105	CcSEcCtD
Fosamprenavir—Fatigue—Methotrexate—multiple sclerosis	0.000301	0.00105	CcSEcCtD
Fosamprenavir—Headache—Betamethasone—multiple sclerosis	0.000301	0.00105	CcSEcCtD
Fosamprenavir—Headache—Dexamethasone—multiple sclerosis	0.000301	0.00105	CcSEcCtD
Fosamprenavir—Asthenia—Prednisone—multiple sclerosis	0.0003	0.00104	CcSEcCtD
Fosamprenavir—Pruritus—Prednisone—multiple sclerosis	0.000296	0.00103	CcSEcCtD
Fosamprenavir—Diarrhoea—Prednisone—multiple sclerosis	0.000286	0.000994	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000286	0.000993	CcSEcCtD
Fosamprenavir—Nausea—Betamethasone—multiple sclerosis	0.000285	0.000991	CcSEcCtD
Fosamprenavir—Nausea—Dexamethasone—multiple sclerosis	0.000285	0.000991	CcSEcCtD
Fosamprenavir—Dizziness—Prednisone—multiple sclerosis	0.000277	0.000961	CcSEcCtD
Fosamprenavir—Abdominal pain—Methotrexate—multiple sclerosis	0.000276	0.00096	CcSEcCtD
Fosamprenavir—Body temperature increased—Methotrexate—multiple sclerosis	0.000276	0.00096	CcSEcCtD
Fosamprenavir—Vomiting—Prednisone—multiple sclerosis	0.000266	0.000924	CcSEcCtD
Fosamprenavir—Rash—Prednisone—multiple sclerosis	0.000264	0.000916	CcSEcCtD
Fosamprenavir—Dermatitis—Prednisone—multiple sclerosis	0.000263	0.000915	CcSEcCtD
Fosamprenavir—Headache—Prednisone—multiple sclerosis	0.000262	0.00091	CcSEcCtD
Fosamprenavir—Hypersensitivity—Methotrexate—multiple sclerosis	0.000257	0.000895	CcSEcCtD
Fosamprenavir—Asthenia—Methotrexate—multiple sclerosis	0.000251	0.000871	CcSEcCtD
Fosamprenavir—Nausea—Prednisone—multiple sclerosis	0.000248	0.000863	CcSEcCtD
Fosamprenavir—Pruritus—Methotrexate—multiple sclerosis	0.000247	0.000859	CcSEcCtD
Fosamprenavir—Diarrhoea—Methotrexate—multiple sclerosis	0.000239	0.000831	CcSEcCtD
Fosamprenavir—Dizziness—Methotrexate—multiple sclerosis	0.000231	0.000803	CcSEcCtD
Fosamprenavir—Vomiting—Methotrexate—multiple sclerosis	0.000222	0.000772	CcSEcCtD
Fosamprenavir—Rash—Methotrexate—multiple sclerosis	0.00022	0.000766	CcSEcCtD
Fosamprenavir—Dermatitis—Methotrexate—multiple sclerosis	0.00022	0.000765	CcSEcCtD
Fosamprenavir—Headache—Methotrexate—multiple sclerosis	0.000219	0.000761	CcSEcCtD
Fosamprenavir—Nausea—Methotrexate—multiple sclerosis	0.000208	0.000721	CcSEcCtD
